Search Results - "Wong, Robert L"

Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis by Reilly, Margaret C., Gooch, Katherine L., Wong, Robert L., Kupper, Hartmut, van der Heijde, Désirée

“…Objective. To determine the validity, reliability and responsiveness of the Work Productivity and Activity Impairment questionnaire in AS (WPAI:SpA). Methods…”
Get full text

S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis by Brunner, Hermine I, Schulert, Grant S, Sproles, Alyssa, Thornton, Sherry, Cornejo, Gabriel Vega, Antón, Jordi, Cuttica, Ruben, Henrickson, Michael, Foeldvari, Ivan, Kingsbury, Daniel J, Askelson, Margarita, Liu, Jinqi, Mukherjee, Sumanta, Wong, Robert L, Lovell, Daniel J, Martini, Alberto, Ruperto, Nicolino, Grom, Alexei A

“…Juvenile idiopathic arthritis (JIA) comprises a heterogeneous group of conditions that can cause marked disability and diminished quality of life. Data on…”
Get full text

Impact of Age, Sex, Physical Function, Health-related Quality of Life, and Treatment with Adalimumab on Work Status and Work Productivity of Patients with Ankylosing Spondylitis by MAKSYMOWYCH, Walter P, GOOCH, Katherine L, WONG, Robert L, KUPPER, Hartmut, VAN DER HEIJDE, Désirée

“…Objective. To determine factors associated with work in patients with ankylosing spondylitis (AS). Methods. Three hundred fifteen patients with AS were…”
Get full text

Adalimumab Reduces Pain, Fatigue, and Stiffness in Patients with Ankylosing Spondylitis: Results from the Adalimumab Trial Evaluating Long-Term Safety and Efficacy for Ankylosing Spondylitis (ATLAS) by REVICKI, Dennis A, LUO, Michelle P, WORDSWORTH, Paul, WONG, Robert L, CHEN, Naijun, DAVIS, John C

“…Objective To evaluate the effect of adalimumab on pain, fatigue, and stiffness in patients with active ankylosing spondylitis (AS). Methods The Adalimumab…”
Get full text

Beneficial Effects of Adalimumab on Biomarkers Reflecting Structural Damage in Patients with Ankylosing Spondylitis by MAKSYMOWYCH, Walter P, RAHMAN, Proton, SHOJANIA, Kam, OLSZYNSKI, Wojciech P, THOMSON, Glen T. D, BALLAL, Shaila, WONG, Robert L, INMAN, Robert D

“…Objective We analyzed the effects of adalimumab on biomarkers predictive of structural damage in inflammatory arthritis. Methods In a 24-week randomized…”
Get full text

Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis by Revicki, Dennis A, Rentz, Anne M, Luo, Michelle P, Wong, Robert L

“…We evaluated the psychometric characteristics of the Short Form 36 (SF-36) Health Survey and the Functional Assessment of Chronic Illness Therapy…”
Get full text

Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire by Doward, Lynda C, McKenna, Stephen P, Meads, David M, Twiss, James, Revicki, Dennis, Wong, Robert L, Luo, Michelle P

“…The Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire is a unidimensional, disease-specific measure developed in the UK and the Netherlands. This…”
Get full text

Correction: S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis by Brunner, Hermine I, Schulert, Grant S, Sproles, Alyssa, Thornton, Sherry, Cornejo, Gabriel Vega, Antón, Jordi, Cuttica, Ruben, Henrickson, Michael, Foeldvari, Ivan, Kingsbury, Daniel J, Askelson, Margarita, Liu, Jinqi, Mukherjee, Sumanta, Wong, Robert L, Lovell, Daniel J, Martini, Alberto, Ruperto, Nicolino, Grom, Alexei A

Get full text

Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis? by Gooch, Katherine, PhD, Feeny, David, PhD, Wong, Robert L., MD, Kupper, Hartmut, MD, Pangan, Aileen L., MD, Revicki, Dennis A., PhD, van der Heijde, Désirée, MD, PhD

“…Abstract Objective To assess the convergent and discriminative validity of the Health Utilities Index Mark 3 (HUI-3) for patients with ankylosing spondylitis…”
Get full text

Toward Accelerated Authorization and Access to New Medicines for Juvenile Idiopathic Arthritis by Schanberg, Laura E., Ramanan, Athimalaipet V., De Benedetti, Fabrizio, Beukelman, Timothy, Eakin, Guy S., Del Gaizo, Vincent, Ringold, Sarah, Vesely, Richard, Schrandt, Suzanne, Jaki, Thomas, Bili, Androniki, Chung, James B., De Bono, Stephanie, Douglass, Wendy, Enejosa, Jeffrey V., Kanik, Keith S., Knobe, Karin, Kunder, Rebecca, Leite‐Schnell, Juliana C., Suehiro, Ricardo Maisse, Wong, Robert L., Mieszkalski, Kelly L., Marrow, Laura C., Siebenaler, Kristin, Fraulo, Elizabeth, Kimura, Yukiko

“…A meeting was organized to bring together multiple stakeholders involved in the testing and authorization of new medications for juvenile idiopathic arthritis…”
Get full text

Thresholds of patient‐reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics by Maksymowych, Walter P., Gooch, Katherine, Dougados, Maxime, Wong, Robert L., Chen, Naijun, Kupper, Hartmut, van der Heijde, Désirée

“…Objective The patient acceptable symptom state (PASS) is a single‐question outcome tool to assess the level of symptoms at which patients with rheumatic…”
Get full text

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis by van der Heijde, Désirée M, Revicki, Dennis A, Gooch, Katherine L, Wong, Robert L, Kupper, Hartmut, Harnam, Neesha, Thompson, Chris, Sieper, Joachim

“…We evaluated the three-year impact of adalimumab on patient-reported physical function and health-related quality-of-life (HRQOL) outcomes in patients with…”
Get full text

Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasis by Braun, Jürgen, Rudwaleit, Martin, Kary, Sonja, Kron, Martina, Wong, Robert L., Kupper, Hartmut

“…Objectives. To compare the clinical manifestations of spinal disease, peripheral arthritis and enthesitis, and to evaluate the effectiveness of adalimumab in a…”
Get full text

Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion by Rudwaleit, Martin, Olivieri, Ignazio, Boki, Kyriaki A., Griep, Eduard N., Järvinen, Pentti, Wong, Robert L., Kron, Martina, Kary, Sonja, Kupper, Hartmut

“…Objectives. To evaluate the effectiveness and safety of adalimumab in treating patients with AS and advanced structural damage. Methods. Patients with active…”
Get full text

Health‐related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: Results from a randomized controlled study by Davis, John C., Revicki, Dennis, van der Heijde, Désirée M. F., Rentz, Anne M., Wong, Robert L., Kupper, Hartmut, Luo, Michelle P.

“…Objective To evaluate the impact of adalimumab on health‐related quality of life (HRQOL) in patients with active ankylosing spondylitis (AS). Methods Patients…”
Get full text

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two by Haibel, Hildrun, Rudwaleit, Martin, Listing, Joachim, Heldmann, Frank, Wong, Robert L., Kupper, Hartmut, Braun, Jürgen, Sieper, Joachim

“…Objective To evaluate the efficacy and safety of the tumor necrosis factor (TNF) antagonist adalimumab in patients with axial spondylarthritis (SpA) without…”
Get full text

Retraction: Psychometric characteristics of the ankylosing spondylitis quality of life questionnaire, short form 36 health survey, and functional assessment of chronic illness therapy-fatigue subscale by Revicki, Dennis A, Rentz, Anne M, Luo, Michelle P, Wong, Robert L, Doward, Lynda C, McKenna, Stephen P

“…Retraction of Revicki DA, Rentz AM, Luo MP, Wong RL, Doward LC, McKenna SP: Psychometric characteristics of the ankylosing spondylitis quality of life…”
Get full text

Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: Data from a randomized controlled trial by Dougados, Maxime, Luo, Michelle P., Maksymowych, Walter P., Chmiel, Joseph J., Chen, Naijun, Wong, Robert L., Davis, John C., Heijde, DÉsirÉe van der

“…Objective To evaluate the feasibility/acceptability, reliability, external validity, and discriminant capacity of the Patient Acceptable Symptom State (PASS)…”
Get full text

Psychometric characteristics of the ankylosing spondylitis quality of life questionnaire, short form 36 health survey, and functional assessment of chronic illness therapy-fatigue subscale by Revicki, Dennis A, Rentz, Anne M, Luo, Michelle P, Wong, Robert L, Doward, Lynda C, McKenna, Stephen P

Get full text

Headache Caused by Giant Cell Arteritis by Ward, Thomas N, Levin, Morris, Wong, Robert L

“…Giant cell arteritis (GCA) is the most common primary systemic vasculitis in older adults. Patients usually are older than 50 years and have an erythrocyte…”
Get full text